Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai

This study is testing a new AI-assisted tool called Feminai that maps breast tissue to detect suspicious lesions. It aims to evaluate whether this technology can help find breast abnormalities in women who are either going for routine screening or already scheduled for a biopsy. **You may be eligible if...** - You are a woman between 25 and 75 years old - Group 1: You are coming in for routine mammogram screening and your last mammogram was normal or benign (BIRADS 1 or 2) - Group 2: You have a mammogram showing a suspicious finding (BIRADS 4 or 5) and are scheduled for a biopsy **You may NOT be eligible if...** - You are currently being treated for breast cancer - You are pregnant or breastfeeding - You have any implanted metal in your body - You have a condition that prevents you from following study procedures safely Talk to your doctor to see if this trial is right for you.